Furosemide Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Contract SPE2D2-22-D-0140 is an award issued by DLA Troop Support to AvKare LLC for the supply of Furosemide tablets in 20MG, 40MG, and 80MG strengths across various bottle counts. The contract has an estimated five-year total value of 16,701,923.95 dollars, consisting of a base year and four option years. Performance is primarily based at Solco Healthcare in Charlotte, North Carolina, with additional packing support provided by APACE Packaging and R&S Northeast in Fountain Run, Kentucky. The contract has been extended through multiple modifications, with Option Year 4 effective from December 08, 2025, through December 07, 2026. The contract includes stringent pharmaceutical labeling and security requirements, mandating compliance with the Drug Supply Chain Security Act and the use of GS1-128 or HIBCC bar codes meeting ANSI/ISO/IEC quality grade C. Regulatory updates have been incorporated via modifications, including prohibitions on ByteDance covered applications and compliance with the Federal Acquisition Supply Chain Security Act. Administrative changes have also been implemented to align with DoD Class Deviations regarding equal opportunity and environmental management clauses. The agreement is managed by the DLA Troop Support Medical Supply Chain office in Philadelphia, Pennsylvania.
General Info
Contract Value
$0Place of Performance
Charlotte, NC, 28206, USASet-Aside
Awardee
AVKARE LLCAward Issued Date
Timeline
Organization & Contact Information
Full Description
SPE2D2-22-D-0140 P00008 to exercise Option Year 4 effective December 08, 2025 through December 07, 2026.
SPE2D2-22-D-0140 P00007 is modified in accordance with DoD Class Deviation 2025-O0003.
SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025.
SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → DLA Troop Support
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
